152 related articles for article (PubMed ID: 38191717)
81. [Clinical analyses of 24 patients with primary pulmonary NK/T-cell lymphoma].
Qiu YJ; Zhang MZ
Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):40-46. PubMed ID: 32023753
[No Abstract] [Full Text] [Related]
82. High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma.
Bi XW; Wang L; Zhang WW; Sun P; Yan SM; Liu PP; Li ZM; Jiang WQ
PLoS One; 2016; 11(3):e0152842. PubMed ID: 27032016
[TBL] [Abstract][Full Text] [Related]
83. [Application of lymphocytes test in peripheral blood of patients with systemic sclerosis during the treatment].
Ma XB; Zhang XW; Jia RL; Gao Y; Liu HJ; Liu YF; Li YN
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):721-727. PubMed ID: 34393235
[TBL] [Abstract][Full Text] [Related]
84. Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma.
Chen Z; Huang H; Huang H; Yu L; Weng H; Xiao J; Zou L; Zhang H; Liang C; Zhou H; Guo H; Wang Z; Li Z; Wu T; Zhang H; Wu H; Peng Z; Zhai L; Chen X; Liang Y; Hong H; Lin T
Leukemia; 2024 Apr; 38(4):829-839. PubMed ID: 38378844
[TBL] [Abstract][Full Text] [Related]
85. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X
Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352
[TBL] [Abstract][Full Text] [Related]
86. Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy.
Bi XW; Jiang WQ; Zhang WW; Huang JJ; Xia Y; Wang Y; Sun P; Li ZM
Ann Hematol; 2015 Jul; 94(7):1175-84. PubMed ID: 25687842
[TBL] [Abstract][Full Text] [Related]
87. Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization.
Karaarslan S; Hekimgil M; Soydan S; Ertan Y; Doğanavşargil B
Pol J Pathol; 2015 Jun; 66(2):161-9. PubMed ID: 26247530
[TBL] [Abstract][Full Text] [Related]
88. Long-term outcomes of upfront concurrent chemoradiotherapy followed by P-GDP regimen in newly diagnosed early stage extranodal nasal-type NK/T cell lymphoma: A prospective single-center phase II study.
Zhu F; Liu T; Pan H; Xiao Y; Li Q; Liu X; Chen W; Wu G; Zhang L
Medicine (Baltimore); 2020 Aug; 99(33):e21705. PubMed ID: 32872045
[TBL] [Abstract][Full Text] [Related]
89. Clinical significance of regulatory T cells and T lymphocyte subsets in peripheral blood in neoadjuvant chemotherapy for breast cancer.
Mao XD; Chen SZ; Shen SQ; Liu KS
Am J Cancer Res; 2023; 13(7):3091-3099. PubMed ID: 37559980
[TBL] [Abstract][Full Text] [Related]
90. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.
Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL
Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679
[TBL] [Abstract][Full Text] [Related]
91. Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma.
Zhang XW; Bi XW; Liu PP; Liu ZL; Nie M; Yang H; Lei DX; Xia Y; Jiang WQ; Zeng WA
Front Oncol; 2020; 10():1360. PubMed ID: 32850435
[No Abstract] [Full Text] [Related]
92. c-Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T-cell lymphoma.
Zhu L; Zhang X; Fu X; Li Z; Sun Z; Wu J; Wang X; Wang F; Li X; Niu S; Ding M; Yang Z; Yang W; Yin M; Zhang L; Zhang M
J Cell Biochem; 2019 Aug; 120(8):12628-12637. PubMed ID: 30825244
[TBL] [Abstract][Full Text] [Related]
93. [Clinical characteristics and prognostic analysis of advanced-stage extranodal NK/T cell lymphoma].
Wei C; Zhang Y; Wang W; Zhang L; Zhang W; Zhou DB
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):462-468. PubMed ID: 32654458
[No Abstract] [Full Text] [Related]
94. Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
Yamaguchi M; Takata K; Yoshino T; Ishizuka N; Oguchi M; Kobayashi Y; Isobe Y; Ishizawa K; Kubota N; Itoh K; Usui N; Miyazaki K; Wasada I; Nakamura S; Matsuno Y; Oshimi K; Kinoshita T; Tsukasaki K; Tobinai K
Cancer Sci; 2014 Nov; 105(11):1435-41. PubMed ID: 25181936
[TBL] [Abstract][Full Text] [Related]
95. Diagnostic value of IL-22, IL-23, and IL-17 for NK/T cell lymphoma.
Qi Y; Liao B; Chen J; Liang C; Chen Z; Xie B
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):150-155. PubMed ID: 37300674
[TBL] [Abstract][Full Text] [Related]
96. A five
Vittayawacharin P; Khuhapinant A
Hematology; 2021 Dec; 26(1):75-82. PubMed ID: 33427594
[TBL] [Abstract][Full Text] [Related]
97. Aberrant peripheral blood CD4
Dehghani M; Kalani M; Golmoghaddam H; Ramzi M; Arandi N
Cancer Immunol Immunother; 2020 Sep; 69(9):1917-1928. PubMed ID: 32385519
[TBL] [Abstract][Full Text] [Related]
98. Comparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK/T-cell lymphoma.
Qi F; Xie Y; Wang D; Chai Y; Chen B; Sun Y; Liu W; Qi S; Wei Y; Fang H; Zhao D; Gui L; Yang Y; Feng X; Ding N; Mi L; Shu S; Li Y; Song Y; Dong M; Zhu J
Ann Hematol; 2022 Sep; 101(9):2021-2034. PubMed ID: 35798977
[TBL] [Abstract][Full Text] [Related]
99. A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type.
Xu PP; Xiong J; Cheng S; Zhao X; Wang CF; Cai G; Zhong HJ; Huang HY; Chen JY; Zhao WL
EBioMedicine; 2017 Nov; 25():41-49. PubMed ID: 29056540
[TBL] [Abstract][Full Text] [Related]
100. Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study.
Qi F; Wang WH; He XH; Chen B; Gui L; Fang H; Liu P; Wang SL; Yang JL; Song YW; Yang S; Qi SN; Zhou SY; Li YX; Dong M
Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):61-70. PubMed ID: 30102205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
